Women's Reviva
Women's Reviva is a collagen and beauty supplement featuring 8 ingredients, positioned for women's wellness. This product includes 150mg of Soy Isoflavones, 100mg of Royal Jelly, 5mg of Lutein, and 10mg of CoQ10, among other botanicals like Reishi and Cordyceps mushrooms. However, none of the listed ingredients are present at dosages considered clinically effective based on current research for their respective benefits. With an N+ Score of 58 and an F grade, this product falls into the average tier, indicating a formulation that may not provide optimal ingredient levels for its intended purpose. The lack of clinically dosed ingredients suggests that its efficacy may be limited. This supplement may appeal to those exploring a multi-ingredient approach to women's health, but higher dosages of individual components are often recommended for targeted effects.
About This Product
Women's Reviva by Life is a collagen & beauty supplement containing 8 active ingredients. It has earned an N+ Score of 58/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (8 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| CoQ10 | 10.000 mg | N/A |
| Lutein | 5.000 mg | N/A |
| Turmeric extract | 50.000 mg | N/A |
| Silica | 50.000 mg | N/A |
| Reishi Mushroom | 100.000 mg | N/A |
| Soy Isoflavones concentrate | 150.000 mg | N/A |
| Royal Jelly 3X | 100.000 mg | N/A |
| Cordyceps sinensis Mushroom | 50.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.